Myxopapillary ependymoma

What factors will increase the chance of having a good outcome following surgery for myxopapillary ependymoma?

The main factor increasing the chance of a good outcome following surgery to treat a myxopapillary ependymoma is complete removal of the tumor during surgery (called gross total resection). In general, one third of patients experience a regrowth (recurrence) of the tumor following surgery; however, only 10% of individuals with gross total resection have a recurrence.

Being older than 35 years of age at the time of diagnosis was also found to increase the chance of a good outcome; it is believed that individuals diagnosed at younger ages have more aggressive disease. Additionally, receiving radiation therapy following surgery was found to increase the chance of a good outcome in one study; this was not found in all studies. Currently, radiation therapy is considered when the entire tumor is not removed by surgery.

Last updated on 05-01-20

What is the success rate for surgery to remove a myxopapillary ependymoma?

Complete removal of the tumor by surgery (gross total resection) was possible in two thirds of patients in one study. The success of surgery in terms of removing the entire tumor depends on the location of the tumor and the type of nervous system structures involved.

Last updated on 05-01-20

What is the outlook for individuals with a myxopapillary ependymoma?

Approximately 98% of individuals with myxopapillary ependymoma are alive five years following diagnosis, and 92% are alive after ten years.

Last updated on 05-01-20

How might myxopapillary ependymoma be treated?

Standard treatment of myxopapillary ependymoma is surgery with the aim of removing as much of the tumor as possible. This tumor type may be cured if all of the tumor is removed during surgery, which is referred to as total resection, and there is usually a favorable outlook in these cases. However, surgery is typically less curative in tumors that are large, multifocal or extend outside the spinal cord. These tumors have the potential to regrow after the initial diagnosis and surgery (recur), particularly in individuals diagnosed as children. Following surgery, radiation therapy may be considered to destroy any cancer cells that could remain in the body. The use of chemotherapy as another treatment of myxopapillary ependymoma remains controversial; chemotherapy has been widely used in pediatric individuals due to more aggressive disease. The usefulness of additional therapies following surgery is unclear for the subset of individuals with recurrence or in individuals in whom total resection cannot be achieved.

Last updated on 05-01-20

Where To Start

American Brain Tumor Association

The American Brain Tumor Association has an information page on Myxopapillary ependymoma. Click on the link to view this information page.

Last updated on 04-27-20

Collaborative Ependymoma Research Network

The Collaborative Ependymoma Research Network , an organization supporting this condition, provides information on Myxopapillary ependymoma

Last updated on 04-27-20

Name: Children's Tumor Foundation CTF 120 Wall Street, 16th floor
New York, NY, 10005-3904, United States
Phone: +1-212-344-6633 Toll Free: 1-800-323-7938 Fax : +1-212-747-0004 Email: Url:
Name: American Brain Tumor Association 8550 W. Bryn Mawr Ave, Ste 550
Chicago, IL, 60631, United States
Phone: +1-773-577-8750 Toll Free: 1-800-886-2282 Fax : +1-773-577-8738 Email: Url:
Name: National Brain Tumor Society 55 Chapel St., Suite 200
Newton, MA, 02458, United States
Phone: +1-617-924-9997 Fax : +1-617-924 -9998 Email: Url:
Name: Pediatric Brain Tumor Foundation 302 Ridgefield Court
Asheville, NC, 28806 , United States
Phone: +1-828-665-6891 Toll Free: 800-253-6530 Fax : +1-828-665-6894 Email: Url:
Name: Children's Brain Tumor Foundation 274 Madison Avenue, Suite 1004
New York, NY, 10016 , United States
Toll Free: 1-866-228-4673 Email: Url:
Name: International Brain Tumour Alliance 10 Carrodus Street, Fraser, ACT, 2615
Email: Url:
Name: Collaborative Ependymoma Research Network CERN Foundation P.O. Box 217
Zionsville, IN, 46077, United States
Phone: (844) 237-6674 Email: Url:

Connect with other users with Myxopapillary ependymoma on the RareGuru app

Do you have information about a disease, disorder, or syndrome? Want to suggest a symptom?
Please send suggestions to RareGuru!

The RareGuru disease database is regularly updated using data generously provided by GARD, the United States Genetic and Rare Disease Information Center.

People Using the App

Join the RareGuru Community

To connect, share, empower and heal today.

People Using the App